Tech Company Financing Transactions
Bird Rock Bio Funding Round
Private investors participated in a $2.5 million funding round for Bird Rock Bio. The round was announced on 1/10/2017.
Transaction Overview
Company Name
Announced On
1/10/2017
Transaction Type
Venture Equity
Amount
$2,500,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. 1 investor participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
2223 Avenida de la Playa 205
La Jolla, CA 92037
USA
La Jolla, CA 92037
USA
Phone
Website
Email Address
Overview
We are developing first-in-class, best-in-class therapeutic antibodies, with significant clinical and commercial differentiation, against biologic targets with substantial human proof of mechanism.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Paul Grayson
Chief Financial Officer
Alyssa Lochbaum
Chief Medical Officer
Alan Glicklich
Chief Technical Officer
Anke Kretz-Rommel
VP - Regulatory Affairs
Shay Tabani
Browse more venture capital transactions:
Prev: 1/7/2017: Flosstime venture capital transaction
Next: 1/10/2017: Kasisto venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC investment data records reported here come from a variety of public sources. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs